Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury

Pinelopi P. Kapitsinou, Hideto Sano, Mark Michael, Hanako Kobayashi, Olena Davidoff, Aihua Bian, Bing Yao, Ming Zhi Zhang, Raymond C. Harris, Kevin J. Duffy, Connie L. Erickson-Miller, Timothy Sutton, Volker H. Haase

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

The hypoxia-inducible transcription factors HIF-1 and HIF-2 mediate key cellular adaptions to hypoxia and contribute to renal homeostasis and pathophysiology; however, little is known about the cell type-specific functions of HIF-1 and HIF-2 in response to ischemic kidney injury. Here, we used a genetic approach to specifically dissect the roles of endothelial HIF-1 and HIF-2 in murine models of hypoxic kidney injury induced by ischemia reperfusion or ureteral obstruction. In both models, inactivation of endothelial HIF increased injury-associated renal inflammation and fibrosis. Specifically, inactivation of endothelial HIF-2α, but not endothelial HIF-1α, resulted in increased expression of renal injury markers and inflammatory cell infiltration in the postischemic kidney, which was reversed by blockade of vascular cell adhesion molecule-1 (VCAM1) and very late antigen-4 (VLA4) using monoclonal antibodies. In contrast, pharmacologic or genetic activation of HIF via HIF prolyl-hydroxylase inhibition protected wild-type animals from ischemic kidney injury and inflammation; however, these same protective effects were not observed in HIF prolyl-hydroxylase inhibitor-treated animals lacking endothelial HIF-2. Taken together, our data indicate that endothelial HIF-2 protects from hypoxia-induced renal damage and represents a potential therapeutic target for renoprotection and prevention of fibrosis following acute ischemic injury.

Original languageEnglish
Pages (from-to)2396-2409
Number of pages14
JournalJournal of Clinical Investigation
Volume124
Issue number6
DOIs
StatePublished - Jun 2 2014

Fingerprint

Kidney
Wounds and Injuries
Prolyl-Hydroxylase Inhibitors
Fibrosis
Integrin alpha4beta1
Prolyl Hydroxylases
Inflammation
Ureteral Obstruction
Wild Animals
Vascular Cell Adhesion Molecule-1
Reperfusion Injury
Homeostasis
Transcription Factors
Monoclonal Antibodies
Hypoxia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kapitsinou, P. P., Sano, H., Michael, M., Kobayashi, H., Davidoff, O., Bian, A., ... Haase, V. H. (2014). Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury. Journal of Clinical Investigation, 124(6), 2396-2409. https://doi.org/10.1172/JCI69073

Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury. / Kapitsinou, Pinelopi P.; Sano, Hideto; Michael, Mark; Kobayashi, Hanako; Davidoff, Olena; Bian, Aihua; Yao, Bing; Zhang, Ming Zhi; Harris, Raymond C.; Duffy, Kevin J.; Erickson-Miller, Connie L.; Sutton, Timothy; Haase, Volker H.

In: Journal of Clinical Investigation, Vol. 124, No. 6, 02.06.2014, p. 2396-2409.

Research output: Contribution to journalArticle

Kapitsinou, PP, Sano, H, Michael, M, Kobayashi, H, Davidoff, O, Bian, A, Yao, B, Zhang, MZ, Harris, RC, Duffy, KJ, Erickson-Miller, CL, Sutton, T & Haase, VH 2014, 'Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury', Journal of Clinical Investigation, vol. 124, no. 6, pp. 2396-2409. https://doi.org/10.1172/JCI69073
Kapitsinou PP, Sano H, Michael M, Kobayashi H, Davidoff O, Bian A et al. Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury. Journal of Clinical Investigation. 2014 Jun 2;124(6):2396-2409. https://doi.org/10.1172/JCI69073
Kapitsinou, Pinelopi P. ; Sano, Hideto ; Michael, Mark ; Kobayashi, Hanako ; Davidoff, Olena ; Bian, Aihua ; Yao, Bing ; Zhang, Ming Zhi ; Harris, Raymond C. ; Duffy, Kevin J. ; Erickson-Miller, Connie L. ; Sutton, Timothy ; Haase, Volker H. / Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury. In: Journal of Clinical Investigation. 2014 ; Vol. 124, No. 6. pp. 2396-2409.
@article{da0238d177f34742a3ef7bb7dc3faea2,
title = "Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury",
abstract = "The hypoxia-inducible transcription factors HIF-1 and HIF-2 mediate key cellular adaptions to hypoxia and contribute to renal homeostasis and pathophysiology; however, little is known about the cell type-specific functions of HIF-1 and HIF-2 in response to ischemic kidney injury. Here, we used a genetic approach to specifically dissect the roles of endothelial HIF-1 and HIF-2 in murine models of hypoxic kidney injury induced by ischemia reperfusion or ureteral obstruction. In both models, inactivation of endothelial HIF increased injury-associated renal inflammation and fibrosis. Specifically, inactivation of endothelial HIF-2α, but not endothelial HIF-1α, resulted in increased expression of renal injury markers and inflammatory cell infiltration in the postischemic kidney, which was reversed by blockade of vascular cell adhesion molecule-1 (VCAM1) and very late antigen-4 (VLA4) using monoclonal antibodies. In contrast, pharmacologic or genetic activation of HIF via HIF prolyl-hydroxylase inhibition protected wild-type animals from ischemic kidney injury and inflammation; however, these same protective effects were not observed in HIF prolyl-hydroxylase inhibitor-treated animals lacking endothelial HIF-2. Taken together, our data indicate that endothelial HIF-2 protects from hypoxia-induced renal damage and represents a potential therapeutic target for renoprotection and prevention of fibrosis following acute ischemic injury.",
author = "Kapitsinou, {Pinelopi P.} and Hideto Sano and Mark Michael and Hanako Kobayashi and Olena Davidoff and Aihua Bian and Bing Yao and Zhang, {Ming Zhi} and Harris, {Raymond C.} and Duffy, {Kevin J.} and Erickson-Miller, {Connie L.} and Timothy Sutton and Haase, {Volker H.}",
year = "2014",
month = "6",
day = "2",
doi = "10.1172/JCI69073",
language = "English",
volume = "124",
pages = "2396--2409",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury

AU - Kapitsinou, Pinelopi P.

AU - Sano, Hideto

AU - Michael, Mark

AU - Kobayashi, Hanako

AU - Davidoff, Olena

AU - Bian, Aihua

AU - Yao, Bing

AU - Zhang, Ming Zhi

AU - Harris, Raymond C.

AU - Duffy, Kevin J.

AU - Erickson-Miller, Connie L.

AU - Sutton, Timothy

AU - Haase, Volker H.

PY - 2014/6/2

Y1 - 2014/6/2

N2 - The hypoxia-inducible transcription factors HIF-1 and HIF-2 mediate key cellular adaptions to hypoxia and contribute to renal homeostasis and pathophysiology; however, little is known about the cell type-specific functions of HIF-1 and HIF-2 in response to ischemic kidney injury. Here, we used a genetic approach to specifically dissect the roles of endothelial HIF-1 and HIF-2 in murine models of hypoxic kidney injury induced by ischemia reperfusion or ureteral obstruction. In both models, inactivation of endothelial HIF increased injury-associated renal inflammation and fibrosis. Specifically, inactivation of endothelial HIF-2α, but not endothelial HIF-1α, resulted in increased expression of renal injury markers and inflammatory cell infiltration in the postischemic kidney, which was reversed by blockade of vascular cell adhesion molecule-1 (VCAM1) and very late antigen-4 (VLA4) using monoclonal antibodies. In contrast, pharmacologic or genetic activation of HIF via HIF prolyl-hydroxylase inhibition protected wild-type animals from ischemic kidney injury and inflammation; however, these same protective effects were not observed in HIF prolyl-hydroxylase inhibitor-treated animals lacking endothelial HIF-2. Taken together, our data indicate that endothelial HIF-2 protects from hypoxia-induced renal damage and represents a potential therapeutic target for renoprotection and prevention of fibrosis following acute ischemic injury.

AB - The hypoxia-inducible transcription factors HIF-1 and HIF-2 mediate key cellular adaptions to hypoxia and contribute to renal homeostasis and pathophysiology; however, little is known about the cell type-specific functions of HIF-1 and HIF-2 in response to ischemic kidney injury. Here, we used a genetic approach to specifically dissect the roles of endothelial HIF-1 and HIF-2 in murine models of hypoxic kidney injury induced by ischemia reperfusion or ureteral obstruction. In both models, inactivation of endothelial HIF increased injury-associated renal inflammation and fibrosis. Specifically, inactivation of endothelial HIF-2α, but not endothelial HIF-1α, resulted in increased expression of renal injury markers and inflammatory cell infiltration in the postischemic kidney, which was reversed by blockade of vascular cell adhesion molecule-1 (VCAM1) and very late antigen-4 (VLA4) using monoclonal antibodies. In contrast, pharmacologic or genetic activation of HIF via HIF prolyl-hydroxylase inhibition protected wild-type animals from ischemic kidney injury and inflammation; however, these same protective effects were not observed in HIF prolyl-hydroxylase inhibitor-treated animals lacking endothelial HIF-2. Taken together, our data indicate that endothelial HIF-2 protects from hypoxia-induced renal damage and represents a potential therapeutic target for renoprotection and prevention of fibrosis following acute ischemic injury.

UR - http://www.scopus.com/inward/record.url?scp=84902172100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902172100&partnerID=8YFLogxK

U2 - 10.1172/JCI69073

DO - 10.1172/JCI69073

M3 - Article

C2 - 24789906

AN - SCOPUS:84902172100

VL - 124

SP - 2396

EP - 2409

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -